Fulgent Genetics (FLGT) Interest & Investment Income (2015 - 2026)

Fulgent Genetics has disclosed Interest & Investment Income across 12 years of filings, most recently posting $8.7 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $8.7 million, up 7.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.6 million (down 1.21% YoY), and the FY2025 annual result was $30.9 million, down 1.23% from the prior year.
• Interest & Investment Income came in at $8.7 million for Q1 2026 at Fulgent Genetics, up from $6.9 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $8.7 million in Q1 2026 to a low of $45000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $6.9 million (2025), against an average of $5.7 million.
• Peak annual rise in Interest & Investment Income reached 9288.57% in 2022, while the deepest fall reached 84.04% in 2022.
• Fulgent Genetics' Interest & Investment Income stood at $3.2 million in 2022, then jumped by 80.66% to $5.8 million in 2023, then jumped by 39.81% to $8.1 million in 2024, then dropped by 14.61% to $6.9 million in 2025, then climbed by 24.73% to $8.7 million in 2026.
• The last three Interest & Investment Income figures came in at $8.7 million (Q1 2026), $6.9 million (Q4 2025), and $7.9 million (Q3 2025), per Business Quant data.